Skip to main content

My account

Boston Scientific accounts are for healthcare professionals only.

Create an account to access online training and education on EDUCARE, manage your customer profile, and connect with customer support and service teams.

My Boston Scientific account

Access your online applications and manage your customer profile.

Manage my Boston Scientific account

Quick Links

Contact a representative Online education and training Order products online Reimbursement resources Return a product Customer support

Call customer care

1 (888) 272-1001

Jetstream™

Atherectomy System

The JET Registry1


Objective

The JET Registry observed the treatment effects of the Jetstream™ Atherectomy System in peripheral arterial disease of the common femoral, superficial femoral, or popliteal arteries.

Patient and Lesion Characteristics​

JET Registry patients had real-world, long, femoropopliteal lesions and slightly over one-third were occluded. Calcium was visible in 90% of the lesions and grade 3 and 4 calcium was present in 47.7% of lesions.

Key Resources

Indications, Safety and Warnings
Sign-Up for
Atherectomy Updates
icon-contact-email

Request a Sales Rep

 icon-send-questions.png

Submit Your Questions
Lesion Calcium Grades
19.5%4 is dense circumferential calcification along the segment length
28.2%3 is aggregate calcification representing >50% of the segment length
24.1%2 is aggregate calcification representing <50% of the segment length
16.2%1 is one individual segment of vessel calcification representing <25% of the length of the entire segment
10.0%0 is no visible calcification
 

Efficacy and Outcomes

At 12 months, results showed:

* Patency based on a DUS PSVR ≤2.5; Binary Restenosis was reported as 22.8%.  The JET Registry had limited DUS follow-up at 12 months (57/241 patients)
 

Patient Safety

JET Registry results demonstrated a strong safety profile.
56% diabetic patients; 0 distal protection utilized

Procedural Details

Catheter Sizes

• 47.2% used 2.1/3.0 mm
• 49.4% used 2.4/3.4 mm

Number of Passes (average*)

• 2.0 blades down
• 1.8 blades up

Embolic Protection

• 22.4% of cases
 

Jetstream Runtime (average*)

• 4.7 minutes
 

* Jetstream Runtime: 4.7 minutes ± 3.5 minutes; Number of Passes: 2.0 blades down ± 1.5 passes and 1.8 blades up ± 1.4 passes. There were no clear stenting parameters set, stent placement was performed at operator’s discretion, and 84 patients (35%) received adjunctive stents.
 

Subgroup Results

At 12 months, results showed:
Number of Patients: Non-Stent (157), Stent (84), Diabetic (99). Patency based on a DUS PSVR ≤2.5; Binary Restenosis Reported: Non-Stent: 20.5%; Stent: 27.8%; Diabetic Patients: 33.3%. The study was not powered to show differences between groups.

Summary

JET Registry data demonstrated:

  • The JET Registry saw a 77.2% patency†† rate in patients with real-world, long femoropopliteal lesions (16.4 cm). No DCBs were used in this study 
  • There was a high freedom from TLR rate of 81.7% at 12 months
  • There was a low distal embolization rate, 1.4% or 3 events
  • Calcium was present in most of the lesions and grade 3 and 4 calcium was present in 47.7% of lesions
  • The Jetstream Atherectomy System had a high procedural success rate, 98.3% of patients had ≤30% residual diameter stenosis post-procedure

†† Patency based on a DUS PSVR ≤2.5; Binary Restenosis was reported as 22.8%.

Top